Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer
<b>Background</b>: Subtype classification for breast cancer (BC) patients is important for risk-stratification. Unfortunately, this parameter is not always able to discriminate between high- and low-risk diseases. Glutamate Carboxypeptidase-II (GCPII), also known as prostate-specific membrane antige...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2026-03-01
|
| Seria: | Biomedicines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/2227-9059/14/3/628 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
